These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16307707)

  • 1. Effect of nesiritide on renal function: a retrospective review.
    Cheng JW; Merl MY; Nguyen HM
    Curr Med Res Opin; 2005 Nov; 21(11):1857-63. PubMed ID: 16307707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S; Clarke K; Srinivasan V; Gradman A
    QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL; Peng JT; Okamoto MP; Heywood JT
    Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
    Sackner-Bernstein JD; Skopicki HA; Aaronson KD
    Circulation; 2005 Mar; 111(12):1487-91. PubMed ID: 15781736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
    Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nesiritide utilization evaluation in a university teaching hospital.
    Cheng JW; Merl MY; Nguyen HM; Caliendo GC; Meyers J
    J Clin Pharm Ther; 2005 Oct; 30(5):447-53. PubMed ID: 16164491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction.
    Kelesidis I; Mazurek J; Khullar P; Saeed W; Vittorio T; Zolty R
    Congest Heart Fail; 2012; 18(3):158-64. PubMed ID: 22497779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.
    Chen HH; Sundt TM; Cook DJ; Heublein DM; Burnett JC
    Circulation; 2007 Sep; 116(11 Suppl):I134-8. PubMed ID: 17846293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL; Kurien S; Warfield KT; Wood CM; Jaffe AS
    Int J Cardiol; 2008 May; 126(2):234-9. PubMed ID: 17482692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
    Yancy CW; Singh A
    Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
    Chow SL; O'Barr SA; Peng J; Chew E; Pak F; Quist R; Patel P; Patterson JH; Heywood JT
    J Card Fail; 2011 Mar; 17(3):181-7. PubMed ID: 21362524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
    Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
    J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.